Global burden of diabetes mellitus 1990–2021: epidemiological trends, geospatial disparities, and risk factor dynamics

Diabetes mellitus(DM) remains a significant global health challenge, characterized by high incidence and Disability-adjusted life years (DALYs) rates. A comprehensive understanding of the disease burden of DM is crucial for developing effective prevention and treatment strategies. This study analyzes the global burden of diabetes mellitus (DM) from 1990 to 2021 using data from the Global Burden of Disease Study. In 2021, DM caused 1.66 million deaths, with age-standardized mortality rising by 7.95% since 1990. While Type 1 diabetes (T1DM) mortality declined by 29.24%, Type 2 diabetes (T2DM) accounted for 97.1% of deaths, with a 9.75% mortality increase. Geospatial analysis revealed extreme disparities: Pacific Island nations exhibited incidence rates >800/100,000, contrasting with <3/100,000 in Costa Rica and China. T1DM burden predominated in high-latitude regions (e.g., Finland), whereas T2DM mirrored overall DM distribution. DALYs for T2DM surged by 42.32%, disproportionately affecting Low-SDI regions. Age-stratified analyses identified distinct patterns: T2DM incidence peaked at 59-69 years, while T1DM DALYs peaked in early-middle adulthood (40-44 years). Risk factor hierarchies highlighted metabolic risks (e.g., high BMI) for T2DM and ambient temperature effects for T1DM. Despite progress in T1DM management, rising T2DM burden underscores urgent need for targeted prevention strategies addressing obesity, dietary risks, and environmental determinants. Study limitations include potential GBD data inaccuracies and ecological design constraints. These findings emphasize the imperative for region-specific interventions to mitigate the evolving diabetes pandemic.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2025-07-01
DOI
https://doi.org/10.3389/fendo.2025.1596127
Citations
19
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
34.53

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Global burden of diabetes mellitus 1990–2021: epidemiological trends, geospatial disparities, and risk factor dynamics

Han-hua Fang, Wei Luo, Yang Liu, Shuhan Zhang et al.
19 citations
Frontiers in Endocrinology
Diabetes and associated disorders
34.53
article

Global burden of diabetes mellitus 1990–2021: epidemiological trends, geospatial disparities, and risk factor dynamics

Han-hua Fang, Wei Luo, Yang Liu, Shuhan Zhang, Yuanjie Wu, Chuyu Pan, Bing-Zhen Cao
article en
19 citations

Abstract

Diabetes mellitus(DM) remains a significant global health challenge, characterized by high incidence and Disability-adjusted life years (DALYs) rates. A comprehensive understanding of the disease burden of DM is crucial for developing effective prevention and treatment strategies. This study analyzes the global burden of diabetes mellitus (DM) from 1990 to 2021 using data from the Global Burden of Disease Study. In 2021, DM caused 1.66 million deaths, with age-standardized mortality rising by 7.95% since 1990. While Type 1 diabetes (T1DM) mortality declined by 29.24%, Type 2 diabetes (T2DM) accounted for 97.1% of deaths, with a 9.75% mortality increase. Geospatial analysis revealed extreme disparities: Pacific Island nations exhibited incidence rates >800/100,000, contrasting with <3/100,000 in Costa Rica and China. T1DM burden predominated in high-latitude regions (e.g., Finland), whereas T2DM mirrored overall DM distribution. DALYs for T2DM surged by 42.32%, disproportionately affecting Low-SDI regions. Age-stratified analyses identified distinct patterns: T2DM incidence peaked at 59-69 years, while T1DM DALYs peaked in early-middle adulthood (40-44 years). Risk factor hierarchies highlighted metabolic risks (e.g., high BMI) for T2DM and ambient temperature effects for T1DM. Despite progress in T1DM management, rising T2DM burden underscores urgent need for targeted prevention strategies addressing obesity, dietary risks, and environmental determinants. Study limitations include potential GBD data inaccuracies and ecological design constraints. These findings emphasize the imperative for region-specific interventions to mitigate the evolving diabetes pandemic.

Frontiers in EndocrinologyVol. 16
Nanjing University of Chinese Medicine (CN), Anhui Medical University (CN), Anhui University of Traditional Chinese Medicine (CN), First Affiliated Hospital of Anhui Medical University (CN), Yunnan University of Traditional Chinese Medicine (CN), Nanjing Medical University (CN)
Natural Science Foundation of Anhui Province
Good health and well-being
Openalex Percentile: Top 0%
Diabetes and associated disorders
34.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.